The launch of NCRI’s Cellular Molecular Pathology initiative (CM-Path) took place on 6 June. Funders, NCRI Partners, consumers and CM-Path members came together to set a strategy for the next five years. Plans developed on the day by each of the initiative’s four workstreams will now be reviewed by the CM-Path Executive Group and, following approval, CM-Path members will begin to implement their strategies. Further information will be available soon. In the meantime you can view the highlights of the day on our latest Storify feed.

View the Twitter highlights of the launch